Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma

Pediatr Transplant. 2011 Sep;15(6):573-9. doi: 10.1111/j.1399-3046.2011.01528.x. Epub 2011 Jul 29.

Abstract

The outcome of HCC after transplantation (OLT) in children is not well known. Unfavorable features based on adult reports may lead to contraindicate OLT even in children. We reviewed a cohort of children with cirrhosis and HCC to evaluate their outcome after primary transplantation. We considered children with cirrhosis and HCC who had a primary OLT. We retrospectively recorded demographic, medical and surgical features, and MC as predictors of outcome. Among 456 children transplanted in the last 15 yr, 10 (2%), median age at diagnosis 1.8 yr (range 0.5-7.2), had HCC in biliary atresia (3), BSEP deficiency (3), tyrosinemia type 1 (2), complications of choledocal cyst and glycogen storage disease type IV (1 each). At HCC discovery, median AFP was 2322 ng/mL (3-35,000), high or rising in 9/10 patients. Six patients were outside the MC. Median time on the waiting list was 38 days (1-152). Two patients died from early complications of OLT. In the other eight patients, there was no tumor recurrence after a median follow-up of four yr. Children with cirrhosis may develop HCC at a very young age. The outcome appears excellent even outside MC. Primary liver transplantation is advisable for children with cirrhosis, HCC, and no extrahepatic disease.

MeSH terms

  • Carcinoma, Hepatocellular / therapy*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Liver Cirrhosis / therapy*
  • Liver Neoplasms / therapy*
  • Liver Transplantation / adverse effects
  • Liver Transplantation / methods*
  • Male
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Immunosuppressive Agents